Skip to main content
Signal8

Sy Jennifer

SEC insider (Form 3/4/5 filer). CIK 0002023998. PRINCIPAL ACCOUNTING OFFICER at AEON Biopharma, Inc. (AEON). 4 reported Form 4/5 transactions since Sep 2024; latest on Mar 4, 2026. Located in IRVINE, CA.

Companies Sy Jennifer has filed insider reports for

  • AEON Biopharma, Inc. (AEON): Officer, PRINCIPAL ACCOUNTING OFFICER
Sy Jennifer profile photo

Sy Jennifer

CIK: 0002023998

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AEON Biopharma, Inc. logo
AEON

AEON Biopharma, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • AEON Biopharma, Inc. logo
    AEON

    AEON Biopharma, Inc.

    Mar 4, 2026
    Award
    Direct
    925.9K shares-
  • AEON Biopharma, Inc. logo
    AEON

    AEON Biopharma, Inc.

    Feb 17, 2026
    Award
    Direct
    575K shares-
  • AEON Biopharma, Inc. logo
    AEON

    AEON Biopharma, Inc.

    May 21, 2025
    Award

    Restricted Stock Units

    Direct
    925.9K shares-
  • AEON Biopharma, Inc. logo
    AEON

    AEON Biopharma, Inc.

    Aug 31, 2024
    Award
    Direct
    18K shares-

1-4 of 4